The global biomaterial market is poised for unprecedented expansion, with forecasts indicating a surge from its 2023 valuation of USD 172,689.3 million to an estimated USD 386,983.6 million by 2033. This robust growth trajectory, translating to a compound annual growth rate (CAGR) of 8.4% in the biodegradable biomaterial sector, underscores a promising outlook for the market over the coming decade.
This extraordinary growth highlights the increasing significance of biomaterials across a broad spectrum of industries, particularly in healthcare and environmental sustainability. Biomaterials are becoming instrumental in driving innovation and addressing critical global challenges, ranging from advancing cutting-edge medical treatments to fostering eco-friendly practices.
The remarkable rise in the biomaterial market is emblematic of a broader shift towards sustainable and biodegradable solutions. As the demand for environmentally conscious materials escalates and biotechnology advances rapidly, the biomaterial industry is set to revolutionize sectors such as healthcare, packaging, and consumer goods. This transformation is not only propelling a move towards greener, more sustainable practices but also contributing significantly to global economic progress.
The projected growth in the biomaterial market presents substantial opportunities for investors, innovators, and industry stakeholders eager to engage with this dynamic sector. The market’s expansion is a testament to a global commitment to sustainability and environmentally responsible solutions, reflecting a collective effort to address pressing environmental issues.
As we advance towards a more sustainable future, the biomaterial market stands as a beacon of innovation and progress. It is driving transformative changes across industries, reshaping the way we approach environmental challenges, and showcasing the sector’s pivotal role in global economic development.
Bridging the Gap Between Science and Healthcare Needs with Biomaterials:
The biomaterials and tissue engineering market is expanding due to the aging population, increased incidence of cardiovascular and orthopedic issues, technical medical developments, and rising public awareness of implantable devices. Increasing consumer awareness of the advantages of products based on biomaterials and increased government funding for biomaterials research and development are contributing to the market expansion.
Compatibility issues and expensive implants are expected to restrict global Biomaterial Market growth. On the other hand, new product introductions in plastic surgery, wound healing, and neurology are anticipated to present lucrative opportunities for growth in the Biomaterial Market. Examples of these products include hydrogen scaffolding and decellularized dermal matrixes for grafting.
The Role of Polymers in Market Revenue for Biomaterials:
The polymer sector dominated the global Biomaterial Market revenue in 2023 and is expected to maintain its dominance. This is attributable mainly to the variety of uses for polymer goods. The segment’s revenue growth is anticipated to accelerate due to the wide availability of biopolymers and the demand for advanced polymers for use in bio-resorbable tissue fixation applications and other orthopedic applications.
“Increasing consumer awareness of the advantages of products based on biomaterials and increased government funding for biomaterials research and development are contributing to the market expansion.” opines Sabyasachi Ghosh Associate Vice President at Future Market Insights (FMI) analyst.
Accelerated Market Demand: Find Comprehensive Insights and Trends in Our Full Report!
Key Takeaways:
- The polymer biomaterials segment of the material type category to grab a share of 33.5% by 2033.
- In the end-user category, the cardiology segment accounts for a market share of 21.1% during the forecast period.
- By 2033, the United States market is expected to possess a 23.2% share.
- The North America market is forecast to have a 28.5% market share by 2033.
- By 2033, Germany is expected to hold 4.7% of the market share.
- Until 2033, the China may grab a share of 8.3%.
- The India market is going to continue to hold a share of 8% through 2033.
- Until 2033, the market in the United Kingdom is anticipated to grab a share of 4%.
- The United States market to exhibit a CAGR of 6% from 2023 to 2033.
- The United Kingdom market to register a CAGR of 5.5% between 2023 and 2033.
- Germany market to develop at a CAGR of 6.1% between 2023 and 2033.
- China market to record a CAGR of 13.3% through 2033.
- India market is to exhibit a CAGR of 15% from 2023 to 2033.
Competitive Analysis:
Important biomaterials manufacturers invest heavily to grow their presence and keep a competitive edge. They are also implementing techniques to improve their product catalog, including contracts, collaborations, and collaborative models. Significant biomaterials manufacturers are prone to creating more inventive items to increase their selection of biomaterials.
Recent Breakthroughs:
- To create bioprinted tissue treatments for obesity and diabetes, Novo Nordisk partnered with Aspect Biosystems, a business that produces bioprinted biomaterials, in April 2023.
- After the Huafon Group purchased DuPont Biomaterials, Covation Biomaterials, a global provider of bio-based solutions, was born as a separate company in June 2022.
- DuPont and JP Modatex India debuted a new spun yarn collection in April 2022 that combines natural fibers with DuPont Sorona staple fibers. The group makes spun yarns appropriate for various uses, including dresses, shirting, pants and skirts, jeans, and jackets, by combining linen and partially plant-based Sorona fibers.
Key Biomaterials Manufacturers:
- BASF SE
- Evonik Industries AG
- Royal DSM N.V.
- Corbion N.V.
- Covestro AG
- Zimmer Biomet Holdings, Inc.
- Stryker Corporation
- Medtronic plc
- DENTSPLY SIRONA Inc.
- Wright Medical Group N.V.
- Baxter International Inc.
- Integra LifeSciences Holdings Corporation
- Johnson & Johnson
- Carpenter Technology Corporation
- Invibio Ltd.
- CAM Bioceramics B.V.
- Biomatlante
- Biomet, Inc.
- Aap Implantate AG
- Orthofix Medical Inc.
Key Segments:
By Material Type:
- Ceramic Biomaterials
- Surface Reactive/Bioactive
- Non-Absorbable
- Polymer Biomaterials
- Metallic Biomaterials
- Natural Materials
- Other Materials
By Application:
- Cardiology
- Ophthamology
- Dental
- Neurology
- Orthopaedic
- Respiratory
- Wound Management
- Aesthetic & Plastic Surgery
- Tissue Engineering & Regenerative Medicine
- Other Applications
By End Users:
- Pharmaceuticals/Biotech Manufacturers
- Medical Device Manufacturers
- Cosmetic & Aesthetic Products Manufacturers
- Tissue Engineering and Regenerative Medicine Companies
- Research Laboratories
- Acaedmic Institutions
By Region:
- North America
- Latin America
- East Asia
- South Asia Pacific
- Western Europe
- Eastern Europe
- The Middle East & Africa
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube
